Showing results (921-930 of 1,155) with videos related to

Sort By:
Pageof 116
Cancers|June 22, 2023
Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut) for the Treatment of NPM1mut-Acute Myeloid LeukemiaMarica De Cicco, Ivana Lagreca, Sabrina Basso, et al.
Bone Marrow Transplantation|November 12, 2014
Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the aieop AML-2002/01 studyF Locatelli, R Masetti, R Rondelli, et al.
British Journal of Haematology|November 22, 2018
Risk factors affecting outcome of unrelated cord blood transplantation for children with familial haemophagocytic lymphohistiocytosisJuliana Montibeller Furtado-Silva, Annalisa Paviglianiti, Annalisa Ruggeri, et al.
Frontiers in Genetics|August 6, 2021
Cohort Analysis of 67 Charcot-Marie-Tooth Italian Patients: Identification of New Mutations and Broadening of Phenotype Expression Produced by Rare VariantsRosangela Ferese, Rosa Campopiano, Simona Scala, et al.
British Journal of Haematology|November 28, 2008
Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained responseEmilia Parodi, Elisa Rivetti, Giovanni Amendola, et al.
Molecular Cytogenetics|October 3, 2012
Chromosome anomalies in bone marrow as primary cause of aplastic or hypoplastic conditions and peripheral cytopenia: disorders due to secondary impairment of RUNX1 and MPL genesCristina Marletta, Roberto Valli, Barbara Pressato, et al.
The Journal of Clinical Investigation|March 5, 2019
Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacityStefania Crippa, Valeria Rossella, Annamaria Aprile, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2019
Clofarabine and Treosulfan as Conditioning for Matched Related and Unrelated Hematopoietic Stem Cell Transplantation: Results from the Clo3o Phase II TrialJacopo Peccatori, Sara Mastaglio, Fabio Giglio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2017
Half-dose fingolimod for treating relapsing-remitting multiple sclerosis: Observational studyChiara Zecca, Arianna Merlini, Giulio Disanto, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 11, 2012
Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejectionF Ginevri, A Nocera, P Comoli, et al.
Pageof 116